About IMEDICA s.r.o.
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Pfizer
1
R-Pharm International, LLC
1
Sandoz
1
Clinical Trials at IMEDICA s.r.o.
During the past decade, IMEDICA s.r.o. conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 3 clinical trials were completed, i.e. on
average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 2 clinical trials were completed. i.e. 200%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Clinical Trial to Compare Treatment With GP2017 and Humira® in Patients With Rheumatoid Arthritis
2016-03-31
2017-09-26
Completed
353
Efficacy and Safety of Olokizumab in Subjects With Moderately to Severely Active Rheumatoid Arthritis
2017-07-04
2021-09-01
Completed
2,106
A Comparative Study Between PF-06410293 and Humira® in Combination With Methotrexate in Participants With Active Rheumatoid Arthritis
2020-01-13
2021-06-22
Completed
455
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "IMEDICA s.r.o."
#1 collaborator was "Hexal AG" with 1 trials as a collaborator, "IQVIA Pvt. Ltd" with 1 trials as a collaborator and "OCT Clinical Trials" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were
collaborators in the rest 3 trials.
Clinical Trials Conditions at IMEDICA s.r.o.
According to Clinical.Site data, the most researched conditions in "IMEDICA s.r.o." are
"Rheumatoid Arthritis" (3 trials). Many other conditions were trialed in "IMEDICA s.r.o." in a lesser frequency.
Clinical Trials Intervention Types at IMEDICA s.r.o.
Most popular intervention types in "IMEDICA s.r.o." are "Drug" (2 trials) and "Biological" (1 trials). Other intervention types were less common.
The name of intervention was led by "Adalimumab - GP2017" (1 trials), "Adalimumab - US licensed Humira" (1 trials), "Concomitant treatment" (1 trials), "Olokizumab 64 mg SC q2w" (1 trials) and "Olokizumab 64 mg SC q4w" (1 trials). Other intervention names were less common.
Clinical Trials Genders at IMEDICA s.r.o.
The vast majority of trials in "IMEDICA s.r.o." are
3 trials for "All" genders.
Clinical Trials Status at IMEDICA s.r.o.
Currently, there are NaN active trials in "IMEDICA s.r.o.".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 3 completed trials in IMEDICA s.r.o.,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in IMEDICA s.r.o., 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 3 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".